BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.30 Cr | ₹3.59 Cr | ₹-3.33 Cr | ₹1.32 Cr | ₹8.21 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BLISS GVS PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.30 Cr |
| Mar2024 | ₹3.59 Cr |
| Mar2023 | ₹-3.33 Cr |
| Mar2022 | ₹1.32 Cr |
| Mar2021 | ₹8.21 Cr |
How is Deferred Tax Assets / Liabilities of BLISS GVS PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.30 Cr | -91.65 | |
| Mar2024 | ₹3.59 Cr | Positive | |
| Mar2023 | ₹-3.33 Cr | Negative | |
| Mar2022 | ₹1.32 Cr | -83.88 | |
| Mar2021 | ₹8.21 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,853.6 Cr | 11.8% | 12.2% | 12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 11.8% |
12.2% |
12% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses